Image pharmaphorum Editor Digital NHS IT glitch ‘caused deaths by cancelling cancer screening’ Health secretary Jeremy Hunt to launch inquiry News BMS strikes three-year cancer R&D deal with Flatiron Bristol-Myers Squibb has struck a three-year with Flatiron Health that aims to make cancer R&D more efficient and patient-focused. News AZ's Tagrisso looks set for first-line lung cancer label in ... Expanded label likely in coming weeks News SMEs: the next generation of pharma The future beyond blockbusters: more precise, more patient-centred and more SME-led. Load more results
Digital NHS IT glitch ‘caused deaths by cancelling cancer screening’ Health secretary Jeremy Hunt to launch inquiry
News BMS strikes three-year cancer R&D deal with Flatiron Bristol-Myers Squibb has struck a three-year with Flatiron Health that aims to make cancer R&D more efficient and patient-focused.
News AZ's Tagrisso looks set for first-line lung cancer label in ... Expanded label likely in coming weeks
News SMEs: the next generation of pharma The future beyond blockbusters: more precise, more patient-centred and more SME-led.
News FDA approves Mirum's oral drug for rare disease FOP Mirum's new oral therapy for rare bone disease fibrodysplasia ossificans progressiva (FOP) looks set to challenge Regeneron's intravenous Pasatru.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
